|
ERLEC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.823600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.247000E-01 |
| Normal-vs-Stage2 |
8.704000E-01 |
| Normal-vs-Stage3 |
3.044000E-01 |
| Normal-vs-Stage4 |
7.393600E-01 |
| Stage1-vs-Stage2 |
4.497800E-01 |
| Stage1-vs-Stage3 |
8.203700E-02 |
| Stage1-vs-Stage4 |
9.322400E-01 |
| Stage2-vs-Stage3 |
5.208000E-01 |
| Stage2-vs-Stage4 |
6.846000E-01 |
| Stage3-vs-Stage4 |
3.474400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.451000E-01 |
| Normal-vs-AfricanAmerican |
7.893800E-01 |
| Normal-vs-Asian |
6.149400E-01 |
| Caucasian-vs-AfricanAmerican |
9.190000E-01 |
| Caucasian-vs-Asian |
4.512600E-01 |
| AfricanAmerican-vs-Asian |
4.943200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.454990E-01 |
| Normal-vs-Female |
5.421200E-03 |
| Male-vs-Female |
2.04230000000472E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.814600E-01 |
| Normal-vs-Extreme_Weight |
1.353380E-01 |
| Normal-vs-Obese |
5.901000E-01 |
| Normal-vs-Extreme_Obese |
4.334400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.799800E-01 |
| Normal_Weight-vs-Obese |
3.347200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.210800E-01 |
| Extreme_Weight-vs-Obese |
5.897800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.641200E-01 |
| Obese-vs-Extreme_Obese |
3.092400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.284050E-01 |
| Normal-vs-Age(41-60Yrs) |
3.106600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.692000E-02 |
| Normal-vs-Age(81-100Yrs) |
1.858560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.416200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.162280E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.875800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.437600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.363550E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.092000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.178000E-01 |
| Normal-VS-Type2 PRCC |
5.095200E-01 |
| Normal-VS-KIRP CIMP |
5.178700E-03 |
| Normal-VS-Unclassified PRCC |
2.128800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.617200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.856260E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.530400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.132490E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.068400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.289400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.238230E-01 |
| Normal-vs-N1 |
3.003400E-01 |
| Normal-vs-N2 |
2.226600E-01 |
| N0-vs-N1 |
3.434300E-02 |
| N0-vs-N2 |
1.392470E-02 |
| N1-vs-N2 |
2.274000E-01 |
|
|
